Oct 15, 2026 · 7 min
Moderna rallies as Dell stumbles and BNY beats expectations
Moderna Gains, Dell Falls, BNY Rises
The episode captures how investor enthusiasm is splitting across healthcare, AI-linked technology, and financial stocks.
- 1Moderna benefits from optimism around its cancer-vaccine partnership with Merck and broader healthcare strength.
- 2Dell suffers its sharpest two-day decline since tariff turmoil as AI-linked technology stocks weaken.
- 3Bank of New York Mellon rises after beating earnings expectations and lifting its 2026 growth outlook.
Don't miss
Moderna’s rally stands out as optimism around its cancer-vaccine partnership with Merck contrasts with weakness in AI-linked technology stocks.
The brief
Moderna leads the healthcare discussion, with optimism around its cancer-vaccine partnership with Merck, upcoming investor events, and clinical-trial data supporting its rally.
The episode then turns to Dell Technologies, whose steep two-day decline reflects weakness across AI-linked technology stocks despite its strong performance earlier in the year.
Bank of New York Mellon moves higher after beating earnings expectations and raising its 2026 growth outlook, even as the KBW Bank Index remains in correction territory.
A closing preview shifts from markets to cities, examining how AI, innovative infrastructure, and long-term planning could help manage rapid urbanization, including Dubai’s response.